Results 11 to 20 of about 100,395 (290)

Polycystic ovary syndrome

Nature Reviews Disease Primers
Despite affecting ~11-13% of women globally, polycystic ovary syndrome (PCOS) is a substantially understudied condition. PCOS, possibly extending to men's health, imposes a considerable health and economic burden worldwide. Diagnosis in adults follows the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary ...
Elisabet Stener-Victorin, Helena Teede, Robert J. Norman, Richard Legro, Mark O. Goodarzi, Anuja Dokras, Joop Laven, Kathleen Hoeger, Terhi T. Piltonen   +8 more
exaly   +7 more sources

Methylglyoxal-dependent glycative stress and deregulation of SIRT1 functional network in the ovary of PCOS mice [PDF]

, 2020
Advanced glycation end-products (AGEs) are involved in the pathogenesis and consequences of polycystic ovary syndrome (PCOS), a complex metabolic disorder associated with female infertility.
Amicarelli, F, Cristiano, L, D'Alessandro, AM, Emidio, GD, Falone, S, Nottola, S, Palmerini, MG, Placidi, M, Rea, F, Rossi, G, Tatone, C   +10 more
core   +1 more source

Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females [PDF]

, 2013
<p>Objectives: Epidemiological evidence for associations of Anti-Müllerian hormone (AMH) with cardiometabolic risk factors is lacking. Existing evidence comes from small studies in select adult populations, and findings are conflicting. We aimed to
A Bayrak, A La Marca, A La Marca, A Piouka, Abigail Fraser, AC Hergenroeder, AM Wallace, Andrea Cignarella, AZ Steiner, B Schwartz, BC Gladen, C Levy-Marchal, C Mattocks, C Villarroel, CJ Riddoch, CP Hagen, CP Hagen, Debbie A. Lawlor, E Buyuk, E Codner, EB Johnstone, Emma L. Anderson, EW Freeman, FB Hu, GF Kerkhof, GS Berenson, Hany Lashen, HM Blanck, HT Park, HY Woo, IA van Rooij, JC Rockett, JM Raitakari OT, JP Strong, KR Hansen, L Aksglaede, LG Nardo, M Hickey, M Juonala, MC Chu, MJ Chen, N Gungor, N Morris, Naveed Sattar, P McCarron, P Skalba, R Fleming, R Hart, Richard Fleming, RL Thomson, S Palomba, Scott M. Nelson, SM Nelson, T Freour, T Kelsey, T Sir-Petermann, TW Kelsey, WA Marshall, William McNally, WJK Hehenkamp, WT Friedewald, YH Lin, YT van der Schouw   +62 more
core   +13 more sources

Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study

Therapeutic Advances in Endocrinology and Metabolism, 2021
Background: Polycystic ovary syndrome is known to be the most common hormonal disorder in women of reproductive age. Current evidence shows that regulatory proteins secreted from the adipose tissue called adipokines may have a role in polycystic ovary ...
Gurhan Guney, Mine Islimye Taskin, Ozgur Baykan, Ertan Adali, Selin Gul Tezcan, Serkan Sarikaya, Cihan Kaya, Ezgi Tolu   +7 more
doaj   +1 more source

Polycystic ovary syndrome and obesity: a modern paradigm

RUDN Journal of Medicine, 2022
Polycystic ovary syndrome is a heterogeneous endocrine disease that affects women of childbearing age. The pathogenesis of polycystic ovary syndrome has not been fully studied to date, its paradigm considers the genetic determinism of the manifestation ...
Marina B. Khamoshina, Yulia S. Artemenko, Ayshan A. Bayramova, Valentina A. Ryabova, Mekan R. Orazov   +4 more
doaj   +1 more source

Polycystic ovary syndrome [PDF]

Medicine, 1989
This case illustrates the very common endocrine problem of polycystic ovary syndrome (PCOS). The diagnosis was not clear initially because of the absence of clinical evidence of androgen excess and of a normal random serum luteinizing hormone (LH) concentration.
openaire   +5 more sources

Salivary testosterone measurement in women with and without polycystic ovary syndrome [PDF]

, 2017
Clinical and/or biochemical hyperandrogenism is one of the diagnostic criteria for PCOS. An evaluation of the role of salivary testosterone (salT) and androstenedione (salA) for the diagnosis of PCOS was undertaken in a cross sectional study involving 65
Adaway, Joanne, Al-Qaissi, Ahmed, Atkin, Stephen, Atkin, Stephen L., Dargham, Soha, Dargham, Soha R., Keevil, Brian, Kilpatrick, Eric, Kilpatrick, Eric S., Sathyapalan, Thozhukat   +9 more
core   +1 more source

The role of cholecalciferol deficiency in the pathogenesis of polycystic ovary syndrome

Women's Health, 2020
Objectives: to evaluate and compare clinical presentations, medical history, and laboratory data of patients with polycystic ovary syndrome, including vitamin 25(OH)D3 level. Methods: In total, 81 patients were examined.
Aigul Safi, Mekan Orazov, Svetlana Kalinchenko   +2 more
doaj   +1 more source

The incidence of gestational diabetes mellitus among women with polycystic ovary syndrome: a meta-analysis of longitudinal studies

BMC Pregnancy and Childbirth, 2022
Background Previous studies have shown that polycystic ovary syndrome is a predictor of gestational diabetes mellitus, but we do not know exactly how many polycystic ovary syndrome patients may develop gestational diabetes mellitus.
Qingzi Yan, Dan Qiu, Xiang Liu, Qichang Xing, Renzhu Liu, Yixiang Hu   +5 more
doaj   +1 more source

Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis [PDF]

, 2015
MicroRNAs (miRNA) are a novel class of small noncoding single-stranded RNA molecules that regulate gene expression. There is increasing evidence of their importance in polycystic ovary syndrome (PCOS). The objective was to determine if miRNA-93 and miRNA-
Atkin, S. L., David, R., Gooderham, N. J., Sathyapalan, T.   +3 more
core   +1 more source